Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
Annual Report 10-11 - Elder Pharmaceuticals Ltd.
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cash Flow Statementfor the year ended 31st March 20<strong>11</strong>(A) CASH FLOW FROM OPERATING ACTIVITIES :(` in Lacs)2 0 1 0 - 2 0 1 1 8,906.95 AddAdjustment for 2,679.69 Interest paid 5,929.03 500.55 (<strong>11</strong>5.04) Interest Received (217.39) (5<strong>10</strong>.37) 8,266.47 17,173.42 Working capital changesLess (3,341.28) (8,066.42) (4,234.21) (431.08) <strong>11</strong>,868.63 (4,204.36) CASH GENERATED FROM OPERATIONS 12,969.06 Interest paid (5,929.03) (1,861.00) 5,179.03 Net Cash Flow from Operating Activities - I 5,179.03 (B) CASH FLOW FROM INVESTING ACTIVITIES : (6,466.62) <strong>11</strong>.74 Purchase of Investments 880.28 (500.55) Interest Received 217.39 <strong>11</strong>5.04 Other Income Received 5<strong>10</strong>.37 Net Cash Used in Investing Activities - II (5,232.35) (53.32) 56
Change language